Biotech

Category / Pharmaceuticals & Biotech / Biotech

Sarepta Therapeutics to Present Company Overview at the Needham Annual Healthcare Conference

CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...

Med BioGene Announces Adoption of Advance Notice Policy

VANCOUVER, BRITISH COLUMBIA: Policy Applies to Future Meetings of Shareholders, Including the Upcoming Annual and Special Meeting to Be Held on May 17, 2013 ...

FDA Advisory Committee Recommends Approval of BREO(TM) ELLIPTA(TM) for the Treatment of COPD

LONDON and SOUTH SAN FRANCISCO, CA: ...

Prima BioMed Awarded Japanese Patent for CVac(TM)

SYDNEY, AUSTRALIA: ...

Lorus Therapeutics Signs Research and License Option Agreement with Elanco

TORONTO, ONTARIO: Provides for Development and Commercialization of Selected Compounds ...

Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program

TORONTO, ONTARIO: Corporate refocusing mission completed ...

Life Science Laboratory Construction Conundrum: Build New vs. Renovate, an Industrial Info News Alert

SUGAR LAND, TX: ...

Sunshine Heart, Inc. Closes Public Offering of Common Shares

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

Rapid Micro Biosystems Announces ISO 9001:2008 Certification

BEDFORD, MA: Accreditation for Quality Management System for Design, Manufacture, Installation and Service of the Growth Direct(TM) System ...

Critical Outcome Technologies Inc. Strengthens Investor Communications

LONDON, ONTARIO: Engages Investor Relations Firm ...

Immunovaccine Receives Financial Contribution from the Government of Canada to Provide Support Towards Clinical Studies in Common Respiratory Illness Affecting Both Children and the Elderly

HALIFAX, NOVA SCOTIA: Funding Enables New Opportunities for the Trials of Novel RSV Vaccine ...

Cytovance(R) Biologics to Expand Microbial Manufacturing

OKLAHOMA CITY, OK: ...

Cromos Pharma Opens an Office in the Republic of Georgia

MOSCOW: ...

Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes

CAMBRIDGE, MA: Eteplirsen Manufacturing and Clinical Activities Continue as Planned ...

Tauriga Sciences, Inc. Appoints Stella M. Sung, Ph.D. to Position of Chief Operating Officer Effective Immediately

LOS ANGELES, CA: ...

Med BioGene Announces Date of Annual and Special Meeting

VANCOUVER, BRITISH COLUMBIA: ...

Miraculins Executes Term Sheet to Acquire the SCOUT DS(R) Non-Invasive Diabetes Screening Technology

WINNIPEG, MANITOBA: World's First Non-Invasive Diabetes Test Can Play a Critical Role in Global Diabetes Screening ...

Portola Files Registration Statement for Proposed Initial Public Offering

SOUTH SAN FRANCISCO, CA: ...

Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2013

TORONTO, ONTARIO: ...

ProMetic Begins Trading on OTCQX(R)

LAVAL, QUEBEC: ...

Page 143 von 247: 1 « .. 142 143 144 145 146 147 148 149 150 151 .. » 247

All members:	10 566
Register today:	1
Register yesterday:	0
Members online:	0
Guests online:	115